$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 103.01 | 900 | 92,708 | 0 | 900 to 0 (-100.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 101.58 | 1,200 | 121,899 | 900 | 2.1 K to 900 (-57.14 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 100.01 | 35,400 | 3,540,478 | 2,100 | 37.5 K to 2.1 K (-94.40 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 15.82 | 25,000 | 395,500 | 37,500 | 12.5 K to 37.5 K (+200.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 11.33 | 12,500 | 141,625 | 12,500 | 0 to 12.5 K |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 109.14 | 3,094 | 337,684 | 0 | 3.1 K to 0 (-100.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 108.23 | 15,499 | 1,677,392 | 3,094 | 18.6 K to 3.1 K (-83.36 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 107.39 | 12,606 | 1,353,760 | 18,593 | 31.2 K to 18.6 K (-40.41 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 106.46 | 4,027 | 428,719 | 31,199 | 35.2 K to 31.2 K (-11.43 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 105.31 | 2,274 | 239,479 | 35,226 | 37.5 K to 35.2 K (-6.06 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 11.33 | 12,500 | 141,625 | 37,500 | 25 K to 37.5 K (+50.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 9.30 | 25,000 | 232,500 | 25,000 | 0 to 25 K |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 31.39 | 3,185 | 99,977 | 76,815 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 21.35 | 4,684 | 100,003 | 85,316 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 16.43 | 6,087 | 100,009 | 58,913 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 9.14 | 2,000 | 18,280 | 98,000 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 22.75 | 4,395 | 99,986 | 0 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 13.12 | 6,621 | 86,868 | 0 | |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 9.14 | 2,000 | 18,280 | 50,364 | 48.4 K to 50.4 K (+4.14 %) |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 16.43 | 6,087 | 100,009 | 48,364 | 42.3 K to 48.4 K (+14.40 %) |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 21.35 | 4,684 | 100,003 | 42,277 | 37.6 K to 42.3 K (+12.46 %) |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 31.39 | 3,185 | 99,977 | 37,593 | 34.4 K to 37.6 K (+9.26 %) |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 22.75 | 4,395 | 99,986 | 34,408 | 30 K to 34.4 K (+14.64 %) |
Aug 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 13.12 | 6,621 | 86,868 | 30,013 | 23.4 K to 30 K (+28.30 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 9.30 | 6,250 | 58,125 | 0 | |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 7.10 | 2,500 | 17,750 | 5,000 | |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 131.00 | 350 | 45,850 | 0 | 350 to 0 (-100.00 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 130.06 | 1,800 | 234,100 | 350 | 2.2 K to 350 (-83.72 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 128.79 | 2,667 | 343,479 | 2,150 | 4.8 K to 2.2 K (-55.37 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 128.10 | 3,933 | 503,811 | 4,817 | 8.8 K to 4.8 K (-44.95 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 7.10 | 2,500 | 17,750 | 8,750 | 6.3 K to 8.8 K (+40.00 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 9.30 | 6,250 | 58,125 | 6,250 | 0 to 6.3 K |
Jun 10 2015 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Option Exercise | A | 129.97 | 140,000 | 18,195,800 | 140,000 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | J | 0.00 | 25,844 | 0 | 126,104 | 151.9 K to 126.1 K (-17.01 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | J | 0.00 | 25,844 | 0 | 140,795 | 115 K to 140.8 K (+22.48 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 10.98 | 1,563 | 17,162 | 0 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 63.00 | 1,524 | 96,012 | 3,439 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 63.00 | 37 | 2,331 | 4,963 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 63.00 | 1,667 | 105,021 | 0 | |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 133.12 | 200 | 26,624 | 0 | 200 to 0 (-100.00 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 132.49 | 2,064 | 273,452 | 200 | 2.3 K to 200 (-91.17 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 131.56 | 1,767 | 232,473 | 2,264 | 4 K to 2.3 K (-43.84 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 130.39 | 760 | 99,098 | 4,031 | 4.8 K to 4 K (-15.86 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 63.00 | 1,667 | 105,021 | 4,791 | 3.1 K to 4.8 K (+53.36 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 63.00 | 1,524 | 96,012 | 3,124 | 1.6 K to 3.1 K (+95.25 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 63.00 | 37 | 2,331 | 1,600 | 1.6 K to 1.6 K (+2.37 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 10.98 | 1,563 | 17,162 | 1,563 | 0 to 1.6 K |
May 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 13.12 | 67,379 | 884,012 | 6,621 | |
May 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Sell | S | 125.00 | 67,379 | 8,422,375 | 23,392 | 90.8 K to 23.4 K (-74.23 %) |
May 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 13.12 | 67,379 | 884,012 | 90,771 | 23.4 K to 90.8 K (+288.04 %) |
May 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 112.16 | 2,000 | 224,320 | 2,000 | 0 to 2 K |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 96.45 | 35,125 | 3,387,806 | 35,125 | |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC and Secreta ... | Option Exercise | A | 96.45 | 5,959 | 574,746 | 5,959 | |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 96.45 | 47,625 | 4,593,431 | 47,625 | |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 96.45 | 75,000 | 7,233,750 | 75,000 | |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 96.45 | 8,250 | 795,713 | 8,250 | |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 130.02 | 8,165 | 1,061,613 | 0 | 8.2 K to 0 (-100.00 %) |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 30.09 | 5,000 | 150,450 | 10,000 | |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 27.28 | 5,000 | 136,400 | 0 | |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 130.02 | 10,000 | 1,300,200 | 0 | 10 K to 0 (-100.00 %) |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 30.09 | 5,000 | 150,450 | 10,000 | 5 K to 10 K (+100.00 %) |
Apr 23 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 27.28 | 5,000 | 136,400 | 5,000 | 0 to 5 K |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 27.28 | 9,053 | 246,966 | 5,000 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 27.28 | 947 | 25,834 | 14,053 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 120.00 | 9,053 | 1,086,360 | 0 | 9.1 K to 0 (-100.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 27.28 | 9,053 | 246,966 | 9,053 | 0 to 9.1 K |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 120.00 | 947 | 113,640 | 0 | 947 to 0 (-100.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 27.28 | 947 | 25,834 | 947 | 0 to 947 |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 120.00 | 5,000 | 600,000 | 8,165 | 13.2 K to 8.2 K (-37.98 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 9.30 | 6,250 | 58,125 | 6,250 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 7.10 | 2,500 | 17,750 | 7,500 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 119.38 | 644 | 76,881 | 0 | 644 to 0 (-100.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 118.16 | 1,000 | 118,160 | 644 | 1.6 K to 644 (-60.83 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 117.35 | 2,080 | 244,088 | 1,644 | 3.7 K to 1.6 K (-55.85 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 116.34 | 3,802 | 442,325 | 3,724 | 7.5 K to 3.7 K (-50.52 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 115.29 | 1,224 | 141,115 | 7,526 | 8.8 K to 7.5 K (-13.99 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 7.10 | 2,500 | 17,750 | 8,750 | 6.3 K to 8.8 K (+40.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 9.30 | 6,250 | 58,125 | 6,250 | 0 to 6.3 K |
Mar 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 63.86 | 706 | 45,085 | 2,117 | |
Mar 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 115.00 | 706 | 81,190 | 13,165 | 13.9 K to 13.2 K (-5.09 %) |
Mar 06 2015 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 63.86 | 706 | 45,085 | 13,871 | 13.2 K to 13.9 K (+5.36 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 107.36 | 700 | 75,150 | 0 | 700 to 0 (-100.00 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 106.72 | 3,025 | 322,818 | 700 | 3.7 K to 700 (-81.21 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 105.66 | 2,621 | 276,925 | 3,725 | 6.3 K to 3.7 K (-41.30 %) |
Feb 27 2015 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 104.83 | 3,654 | 383,059 | 6,346 | 10 K to 6.3 K (-36.54 %) |
Feb 02 2015 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 95.00 | 97,118 | 9,226,210 | 10,051,603 | 10 M to 10.1 M (+0.98 %) |
Jan 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | P | 95.00 | 10,000 | 950,000 | 122,825 | 112.8 K to 122.8 K (+8.86 %) |
Jan 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Buy | P | 95.00 | 1,000 | 95,000 | 1,000 | 0 to 1,000 |
Jan 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 95.00 | 647,448 | 61,507,560 | 9,954,485 | 9.3 M to 10 M (+6.96 %) |
Jan 28 2015 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 9,317.00 | 196,251 | 1,828,470,567 | 9,307,037 | 9.1 M to 9.3 M (+2.15 %) |
Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 17,000 | 271,830 | 133,609 | |
Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 97.00 | 2,802 | 271,794 | 18,103 | 20.9 K to 18.1 K (-13.40 %) |
Jan 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 17,000 | 271,830 | 20,905 | 3.9 K to 20.9 K (+435.34 %) |
Dec 22 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 13.12 | 1,000 | 13,120 | 74,000 | |
Dec 22 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 13.12 | 1,000 | 13,120 | 23,392 | 22.4 K to 23.4 K (+4.47 %) |
Dec 22 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Sell | S | 100.00 | 11,200 | 1,120,000 | 22,392 | 33.6 K to 22.4 K (-33.34 %) |
Dec 18 2014 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 96.45 | 30,000 | 2,893,500 | 30,000 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 8,205 | 74,994 | 139,060 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 63.00 | 25,000 | 1,575,000 | 25,000 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 8,205 | 74,994 | 112,825 | 104.6 K to 112.8 K (+7.84 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,251 | 58,134 | 12,500 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 1,875 | 17,138 | 0 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 10,000 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | A | 63.00 | 10,834 | 682,542 | 10,834 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 95.00 | 100 | 9,500 | 0 | 100 to 0 (-100.00 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 94.40 | 5,090 | 480,514 | 100 | 5.2 K to 100 (-98.07 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 93.42 | 2,936 | 274,273 | 5,190 | 8.1 K to 5.2 K (-36.13 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 92.33 | 1,900 | 175,420 | 8,126 | 10 K to 8.1 K (-18.95 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 91.47 | 600 | 54,880 | 10,026 | 10.6 K to 10 K (-5.65 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 2,500 | 17,750 | 10,626 | 8.1 K to 10.6 K (+30.77 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,251 | 58,134 | 8,126 | 1.9 K to 8.1 K (+333.39 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 1,875 | 17,138 | 1,875 | 0 to 1.9 K |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 18.66 | 4,375 | 81,638 | 5,625 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 10.98 | 7,937 | 87,148 | 1,563 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 9.14 | 4,563 | 41,706 | 0 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 7.10 | 3,750 | 26,625 | 3,750 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 63.00 | 1,667 | 105,021 | 1,667 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 103.60 | 820 | 84,952 | 0 | 820 to 0 (-100.00 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 102.56 | 900 | 92,306 | 820 | 1.7 K to 820 (-52.33 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 101.75 | 2,000 | 203,494 | 1,720 | 3.7 K to 1.7 K (-53.76 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 100.52 | 1,835 | 184,447 | 3,720 | 5.6 K to 3.7 K (-33.03 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 99.73 | 1,475 | 147,109 | 5,555 | 7 K to 5.6 K (-20.98 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 98.48 | 900 | 88,635 | 7,030 | 7.9 K to 7 K (-11.35 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 97.12 | 1,400 | 135,965 | 7,930 | 9.3 K to 7.9 K (-15.01 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 95.97 | 4,128 | 396,153 | 9,330 | 13.5 K to 9.3 K (-30.67 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 95.10 | 8,704 | 827,747 | 13,458 | 22.2 K to 13.5 K (-39.27 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 18.66 | 4,375 | 81,638 | 22,162 | 17.8 K to 22.2 K (+24.60 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 7.10 | 3,750 | 26,625 | 17,787 | 14 K to 17.8 K (+26.72 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 10.98 | 7,937 | 87,148 | 14,037 | 6.1 K to 14 K (+130.11 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 9.14 | 4,563 | 41,706 | 6,100 | 1.5 K to 6.1 K (+296.88 %) |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 63.00 | 15,000 | 945,000 | 15,000 | |
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 63.00 | 6,667 | 420,021 | 6,667 | |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 22.09 | 15,000 | 331,350 | 0 | |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 105.00 | 15,000 | 1,575,000 | 0 | 15 K to 0 (-100.00 %) |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 22.09 | 15,000 | 331,350 | 15,000 | 0 to 15 K |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 30.09 | 5,000 | 150,450 | 0 | |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | M | 30.09 | 10,000 | 300,900 | 20,000 | |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 110.00 | 10,000 | 1,100,000 | 13,165 | 23.2 K to 13.2 K (-43.17 %) |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Sell | S | 105.00 | 5,000 | 525,000 | 23,165 | 28.2 K to 23.2 K (-17.75 %) |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 30.09 | 10,000 | 300,900 | 28,165 | 18.2 K to 28.2 K (+55.05 %) |
Dec 10 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Buy | M | 30.09 | 5,000 | 150,450 | 18,165 | 13.2 K to 18.2 K (+37.98 %) |